The sale of Colgate Clean Mint toothpaste was suspended throughout Brazil on Thursday, March 27, 2025, by the National Health Surveillance Agency (Anvisa). This decision came after consumers reported a range of adverse reactions, including swelling, burning lips, and irritated gums. At least eight complaints were lodged regarding the new formulation of Colgate Total 12, which has been on the market since July 2024.
The suspension, which lasts for 90 days, allows Colgate the opportunity to appeal the decision. Anvisa's action was prompted by a concerning number of reports detailing 13 adverse effects associated with the toothpaste. These reports, which span from January 1 to March 19, 2025, highlight a variety of troubling symptoms.
Among the reported symptoms are swelling in the tonsils, lips, and oral mucosa; a burning and numb sensation in the lips and mouth; dry mouth; irritated gums; and redness. The severity of these reactions has raised alarms among health officials and consumers alike.
Colgate has yet to issue a public statement regarding the sales ban as of Thursday. However, in response to the initial reports of adverse reactions, the company previously asserted that the new formula, which contains stannous fluoride, is safe. Colgate emphasized that the product underwent extensive testing with consumers, including trials conducted in Brazil.
Despite these assurances, Colgate acknowledged the possibility that "a small minority of people may experience sensitivity to certain ingredients – such as stannous fluoride, dyes, or flavors." This statement indicates an awareness of the potential for allergic reactions, even in a product that has undergone rigorous testing.
The Clean Mint toothpaste is a revamped version of the popular Colgate Total 12, which has been a staple in many households. The decision to alter the formula and branding was initially positioned as an improvement, but the recent reports have cast a shadow over the product's safety.
As the situation unfolds, consumers are left in a state of uncertainty, questioning the safety of their dental hygiene products. The suspension by Anvisa is a significant move that underscores the importance of consumer safety and regulatory oversight in the market.
In light of these developments, consumers are advised to monitor their health closely and report any adverse reactions they may experience with dental products. The ongoing dialogue between health agencies, manufacturers, and consumers is crucial in ensuring that products on the market meet safety standards.
Meanwhile, Colgate's response to the suspension and the complaints will be closely watched. The company faces a critical moment as it navigates consumer trust and regulatory scrutiny. With the suspension in place, it remains to be seen how Colgate will address these concerns and what steps will be taken to ensure the safety of its products moving forward.
In a market where consumer confidence is paramount, the fallout from this incident could have lasting implications for Colgate and its reputation. As more consumers become aware of the potential risks associated with certain dental products, companies may need to reassess their formulations and testing protocols to prioritize safety and transparency.
Overall, the suspension of Colgate Clean Mint toothpaste serves as a reminder of the critical role that health agencies play in safeguarding public health. It highlights the need for vigilance in monitoring consumer products and the importance of responsive action when safety concerns arise.
As this story develops, further updates from both Anvisa and Colgate will be essential in providing clarity to consumers about the safety of dental hygiene products.
